Shenzhen Ruidi Bio-Pharmaceutical

Shenzhen Ruidi Bio-Pharmaceutical is a clinical-stage biotechnology company based in China that focuses on the discovery and development of innovative antibody-based therapeutics for oncology and autoimmune diseases. The company leverages its proprietary high-throughput antibody screening and engineering platforms to create a pipeline of monoclonal and bispecific antibodies. Its lead programs target well-established immune checkpoints and angiogenic factors, aiming to provide more effective treatment options for various solid tumors. Ruidi Bio is committed to advancing its candidates through clinical trials in China while seeking global development opportunities.